These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2690497)

  • 1. [Prevention of thromboembolism following heart valve replacement].
    van de Loo J; Stenzinger W
    Verh Dtsch Ges Inn Med; 1989; 95():275-82. PubMed ID: 2690497
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of thromboembolism in heart valve diseases and following heart valve replacement].
    Stenzinger W; van de Loo J
    Internist (Berl); 1989 Aug; 30(8):520-4. PubMed ID: 2676892
    [No Abstract]   [Full Text] [Related]  

  • 3. Thromboembolic events in prosthetic valve recipients: what is the safe level of anticoagulation?
    Acar J
    J Heart Valve Dis; 1993 Jul; 2(4):395-7. PubMed ID: 8269141
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for prevention of thromboembolic events in valvular heart disease. Ad Hoc Committee of the Working Group on Valvular Heart Disease, European Society of Cardiology.
    Gohlke-Bärwolf C; Acar J; Burckhardt D; Oakley C; Butchart E; Krayenbühl P; Hall R; Bodnar E; Krzeminska-Pakula M; Delahaye JP
    J Heart Valve Dis; 1993 Jul; 2(4):398-410. PubMed ID: 8269142
    [No Abstract]   [Full Text] [Related]  

  • 5. Can early thromboembolic complications after valve replacement be avoided?
    Kure HH; Schüller H; Thulin L; Olin C
    Z Kardiol; 1986; 75 Suppl 2():302-4. PubMed ID: 3727707
    [No Abstract]   [Full Text] [Related]  

  • 6. Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
    Dale J; Nitter-Hauge S
    Z Kardiol; 1986; 75 Suppl 2():332-7. PubMed ID: 3727714
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulation is necessary in all patients with mechanical prostheses in sinus rhythm.
    Duveau D
    Z Kardiol; 1986; 75 Suppl 2():326-31. PubMed ID: 3727712
    [No Abstract]   [Full Text] [Related]  

  • 8. High complication and failure rates of anticoagulant therapy are unavoidable.
    Nitter-Hauge S; Dale J
    Z Kardiol; 1986; 75 Suppl 2():293-7. PubMed ID: 3727705
    [No Abstract]   [Full Text] [Related]  

  • 9. Five-years actuarial analysis after heart valve replacement with the St. Jude medical prosthesis.
    Fraedrich G; Höge R; Fiedler R; Hehrlein FW
    Z Kardiol; 1986; 75 Suppl 2():282-5. PubMed ID: 3727702
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis.
    Aramendi JL; Agredo J; Llorente A; Larrarte C; Pijoan J
    J Heart Valve Dis; 1998 Nov; 7(6):610-4. PubMed ID: 9870193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitral valve replacement and thromboembolic risk.
    Benussi S; Verzini A; Alfieri O
    J Heart Valve Dis; 2004 May; 13 Suppl 1():S81-3. PubMed ID: 15225011
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of thrombosis in heart valve diseases].
    Meyer BJ; Beer JH
    Ther Umsch; 1998 Dec; 55(12):756-61. PubMed ID: 10025189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of hemorrhagic and thromboembolic complications in heart valve prosthesis].
    Pospelova EP; Stepanian EP; Shchurkalina TKh; Movsesian RA
    Grudn Khir; 1971; 13(1):49-51. PubMed ID: 5577527
    [No Abstract]   [Full Text] [Related]  

  • 14. Low profile bioprostheses for mitral valve replacement.
    Romano M; Sigal R; Lorente P; Piwnica A
    Z Kardiol; 1986; 75 Suppl 2():305-7. PubMed ID: 3727708
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulation is necessary in patients with atrial fibrillation after mitral valve replacement with bioprostheses.
    Rothlin ME
    Z Kardiol; 1986; 75 Suppl 2():317-20. PubMed ID: 3727710
    [No Abstract]   [Full Text] [Related]  

  • 16. [Choice of heart valve prosthesis--1985].
    Borst HG; Frank G; Frimpong-Boateng K; Bednarski P
    Z Kardiol; 1986 Jun; 75(6):311-5. PubMed ID: 3751217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carpentier-Edwards supra-annular porcine bioprosthesis--new generation biological valve.
    Jamieson WR; Gerein AN; Tyers GF; Allen P; Munro AI; Miyagishima RT; Janusz MT; Burr LH
    Z Kardiol; 1986; 75 Suppl 2():245-50. PubMed ID: 3727695
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term prognosis following valvular heart surgery.
    Winters WL; Samuels DA
    Cardiovasc Clin; 1986; 16(2):437-505. PubMed ID: 3488808
    [No Abstract]   [Full Text] [Related]  

  • 19. Managing mechanical valves with reduced anticoagulation.
    Slaughter MS; Jweied E
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1073-85. PubMed ID: 18035923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
    Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C
    Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.